Literature DB >> 12014428

Protective effect of pretreatment with low-dose lipopolysaccharide on D-galactosamine-induced acute liver failure.

Toru Kono1, Hiromi Kotani, Toshiyuki Asama, Noriaki Mamiya, Kei Ohara, Masashi Yoneda, Jun Iwamoto, Shinichi Kasai.   

Abstract

BACKGROUND AND AIMS: The effect of low-dose lipopolysaccharide (LPS) induced nitric oxide (NO) on liver damage and survival in rats with acute liver failure caused by a lethal dose of D-galactosamine (D-gal) was studied.
RESULTS: Ninety percent of control animals died within 4 days after D-gal injection, but pretreatment with low-dose LPS significantly decreased mortality to 5%. There was marked elevation in serum aspartate aminotransferase and alanine aminotransferase levels 24 h after D-gal injection. These aminotransferases were significantly improved in low-dose LPS pretreated rats 24 h after the administration of D-gal. NG-Nitro-L-arginine-methyl ester, but not NG-nitro-D-arginine-methyl ester, reversed this cytoprotection.
CONCLUSION: Pretreatment with low-dose LPS prevents experimental liver failure induced by D-gal through activation of endogenous NO synthesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12014428     DOI: 10.1007/s003840100341

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  2 in total

1.  Hepatoprotective effect of nitric oxide in experimental model of acute hepatic failure.

Authors:  Marek Saracyn; Marek Brytan; Robert Zdanowski; Tomasz Ząbkowski; Przemysław Dyrla; Janusz Patera; Stanisław Wojtuń; Wojciech Kozłowski; Zofia Wańkowicz
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

2.  Feedback loop between hepatocyte nuclear factor 1α and endoplasmic reticulum stress mitigates liver injury by downregulating hepatocyte apoptosis.

Authors:  Si-Ying Liu; Jian-Xu Rao; Jie Deng; Gui-Juan Zhang; Xiao-Ling Jiang; Jing Cheng; Huan Chen; Zhi-Gang Jiang; De-Lin Xu; Yi-Huai He
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.